Thirumalai Chemicals Limited's Board of Directors, at their meeting held on 19 June 2025, approved several key proposals, all subject to the approval of shareholders through an Extraordinary General Meeting (EGM):

• Raising funds up to ₹450.63 crore by issuing up to 1,62,68,040 Equity Shares for cash consideration at a price of ₹277.00 per Equity Share. This will be done through a preferential issue on a private placement basis to various investors, including Motilal Oswal Small Cap Fund, Motilal Oswal Multi Cap Fund, 360 One Equity Opportunity Fund, and various Bandhan funds.
• Alteration of the Company's Articles of Association to insert a new Article 73A concerning the transfer of debentures.
• Pledging of the equity shares of TCL Intermediates Private Limited, a material wholly owned subsidiary of the company.
• Appointment of M/s CRISIL RATINGS LIMITED as a Monitoring Agency to monitor the use of proceeds from the proposed preferential issue.
• Approval of the draft notice for convening an EGM to obtain shareholder approvals for the fund-raising and the pledging of subsidiary shares. DAM Capital Advisors Limited acted as the sole advisor to the company for these matters.